Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $71.77 in the prior trading day, Bio-Techne Corp (NASDAQ: TECH) closed at $71.78, up 0.01%. In other words, the price has increased by $0.01 from its previous closing price. On the day, 0.79 million shares were traded. TECH stock price reached its highest trading level at $72.14 during the session, while it also had its lowest trading level at $70.48.
Ratios:
Our goal is to gain a better understanding of TECH by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 74.00 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 47.91. For the most recent quarter (mrq), Quick Ratio is recorded 2.75 and its Current Ratio is at 3.87. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.20.
On February 08, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $80.
Stifel Downgraded its Buy to Hold on February 02, 2024, while the target price for the stock was maintained at $65.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 08 ’24 when ROBERT V. BAUMGARTNER bought 16,000 shares for $72.10 per share.
BAUMGARTNER ROBERT V sold 16,000 shares of TECH for $1,153,664 on Aug 08 ’24. The Director now owns 43,401 shares after completing the transaction at $72.10 per share. On May 14 ’24, another insider, HIGGINS JOHN L, who serves as the Director of the company, sold 4,000 shares for $83.84 each. As a result, the insider received 335,377 and left with 36,608 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TECH now has a Market Capitalization of 11311450112 and an Enterprise Value of 11598440448. As of this moment, Bio-Techne’s Price-to-Earnings (P/E) ratio for their current fiscal year is 68.88, and their Forward P/E ratio for the next fiscal year is 32.74. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 17.48. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.76 while its Price-to-Book (P/B) ratio in mrq is 5.61. Its current Enterprise Value per Revenue stands at 10.007 whereas that against EBITDA is 36.344.
Stock Price History:
Over the past 52 weeks, TECH has reached a high of $85.57, while it has fallen to a 52-week low of $51.79. The 50-Day Moving Average of the stock is -5.55%, while the 200-Day Moving Average is calculated to be 0.48%.
Shares Statistics:
The stock has traded on average 1.04M shares per day over the past 3-months and 1224020 shares per day over the last 10 days, according to various share statistics. A total of 157.64M shares are outstanding, with a floating share count of 155.93M. Insiders hold about 1.05% of the company’s shares, while institutions hold 100.60% stake in the company. Shares short for TECH as of 1721001600 were 3768678 with a Short Ratio of 3.08, compared to 1718323200 on 5418289. Therefore, it implies a Short% of Shares Outstanding of 3768678 and a Short% of Float of 3.11.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 0.43.
